MBL Wealth »

Neurocrine Biosciences shares owned by MBL Wealth

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by MBL Wealth from 13F filings

Historical chart of MBL Wealth investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by MBL Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by MBL Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $204k 1.5k 131.74

More positions owned by MBL Wealth

State Str Spdr S&p 500 Etf T Put Put Option (Principal) (SPY)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Core S&p Mcp Etf (IJH)
World Gold Tr Spdr Gld Minis (GLDM)
Ishares Core Msci Emkt (IEMG)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Dimensional Etf Trust Natl Mun Bd Etf (DFNM)
Victory Portfolios Ii Core Intermediat (UITB)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr Core Msci Intl (IDEV)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Apple (AAPL)

View all positions for MBL Wealth

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Vestal Point Capital
Millennium Management

View all funds holding Neurocrine Biosciences